These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7965648)

  • 1. Pathogenicity and diversity of HIV and implications for clinical management: a review.
    Saag MS; Hammer SM; Lange JM
    J Acquir Immune Defic Syndr (1988); 1994; 7 Suppl 2():S2-10; discussion S10-1. PubMed ID: 7965648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.
    Kozal MJ; Shafer RW; Winters MA; Katzenstein DA; Aguiniga E; Halpern J; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):832-8. PubMed ID: 7517448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
    Koot M; Keet IP; Vos AH; de Goede RE; Roos MT; Coutinho RA; Miedema F; Schellekens PT; Tersmette M
    Ann Intern Med; 1993 May; 118(9):681-8. PubMed ID: 8096374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children.
    Spencer LT; Ogino MT; Dankner WM; Spector SA
    J Infect Dis; 1994 Mar; 169(3):491-5. PubMed ID: 7908924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.
    Boucher CA; Lange JM; Miedema FF; Weverling GJ; Koot M; Mulder JW; Goudsmit J; Kellam P; Larder BA; Tersmette M
    AIDS; 1992 Nov; 6(11):1259-64. PubMed ID: 1282015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
    J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.
    Roos MT; Lange JM; de Goede RE; Coutinho RA; Schellekens PT; Miedema F; Tersmette M
    J Infect Dis; 1992 Mar; 165(3):427-32. PubMed ID: 1347054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.
    van't Wout AB; Ran LJ; de Jong MD; Bakker M; van Leeuwen R; Notermans DW; Loeliger AE; de Wolf F; Danner SA; Reiss P; Boucher CA; Lange JM; Schuitemaker H
    J Clin Invest; 1997 Nov; 100(9):2325-32. PubMed ID: 9410911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.
    Blaak H; van't Wout AB; Brouwer M; Hooibrink B; Hovenkamp E; Schuitemaker H
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1269-74. PubMed ID: 10655520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivo.
    van 't Wout AB; Ran LJ; Nijhuis M; Tijnagel JM; de Groot T; van Leeuwen R; Boucher CA; Schuitemaker H; Schuurman R
    AIDS; 1998 Jul; 12(10):1169-76. PubMed ID: 9677166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses.
    Peeters M; Vincent R; Perret JL; Lasky M; Patrel D; Liegeois F; Courgnaud V; Seng R; Matton T; Molinier S; Delaporte E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):115-21. PubMed ID: 10048897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.
    van Rij RP; Blaak H; Visser JA; Brouwer M; Rientsma R; Broersen S; de Roda Husman AM; Schuitemaker H
    J Clin Invest; 2000 Oct; 106(8):1039-52. PubMed ID: 11032864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.
    Richman DD; Bozzette SA
    J Infect Dis; 1994 May; 169(5):968-74. PubMed ID: 7909549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
    Tersmette M; Gruters RA; de Wolf F; de Goede RE; Lange JM; Schellekens PT; Goudsmit J; Huisman HG; Miedema F
    J Virol; 1989 May; 63(5):2118-25. PubMed ID: 2564898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity.
    Ercoli L; Sarmati L; Nicastri E; Giannini G; Galluzzo C; Vella S; Andreoni M
    AIDS; 1997 Aug; 11(10):1211-7. PubMed ID: 9256938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo.
    Fouchier RA; Meyaard L; Brouwer M; Hovenkamp E; Schuitemaker H
    Virology; 1996 May; 219(1):87-95. PubMed ID: 8623557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.
    van 't Wout AB; Blaak H; Ran LJ; Brouwer M; Kuiken C; Schuitemaker H
    J Virol; 1998 Jun; 72(6):5099-107. PubMed ID: 9573281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of different HIV-1 phenotypic subpopulations through the natural history of the infection].
    Pérez Alvarez L; Verdejo J; González Lahoz J; Gurbindo D; Hernández-Sampelayo T; Moreno E; Azañedo M; Contreras G; Medrano L; Nájera R
    Med Clin (Barc); 1998 Apr; 110(12):441-5. PubMed ID: 9611711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.